Magnesium is a critical mineral involved in more than 300 enzymatic reactions and plays a central role in neural stability, stress buffering, and circadian regulation.

Among various magnesium salts, magnesium glycinate - where magnesium is chelated to two glycine molecules - demonstrates superior bioavailability, gentle gastrointestinal tolerance, and unique neuro-synergistic actions.

This review summarizes mechanistic pathways and clinical evidence supporting magnesium glycinate as an effective non-pharmacological intervention for depression, anxiety, insomnia, cognitive fatigue, and menopausal symptoms.

Mechanistically, magnesium glycinate acts via four primary axes: 

(1) neurotransmitter modulation (enhancing GABA activity, blocking NMDA overactivation, activating glycine receptors);

(2) HPA axis regulation (lowering ACTH and cortisol, restoring circadian balance);

(3) neuro-muscular relaxation (reducing excitability, easing stress-related muscle tension);

(4) mitochondrial energy restoration (supporting Mg-ATP synthesis, reducing oxidative stress).

Clinical trials consistently demonstrate benefits at daily doses of 200-300 mg elemental magnesium, with magnesium glycinate outperforming inorganic salts in absorption (50–80% vs. <10%) and tolerability.

As part of integrated nutritional strategies, magnesium glycinate is well-positioned as a foundational neuro-regulatory nutrient, particularly when combined with synergistic agents such as L-Theanine, 5-HTP, Ashwagandha, and B-complex vitamins.

Overall, magnesium glycinate represents a structure–mechanism dual-synergy nutrient, bridging molecular neurochemistry with practical emotional and sleep health interventions.